Erratum: Reducing the dietary omega-6:omega-3 utilizing a-linolenic acid; not a sufficient therapy for attenuating high-fat-diet-induced obesity development nor related detrimental metabolic and adipose tissue inflammatory outcomes (PLoS ONE (2014) 9, 4 (e94897) DOI: 10.1371/journal.pone.0094897);Reducing the dietary omega-6: Omega-3 utilizing α-linolenic acid; Not a sufficient therapy for attenuating high-fat-diet-induced obesity development nor related detrimental metabolic and adipose tissue inflammatory outcomes

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Enos, Reilly T ^a   Velázquez, Kandy T ^a   McClellan, Jamie L ^a   Cranford, Taryn L ^a   Walla, Michael D ^b   Murphy, E Angela ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CD206 ANTIGEN; CHOLESTEROL; CXCL14 CHEMOKINE; DOCOSAHEXAENOIC ACID; FETUIN A; G PROTEIN COUPLED RECEPTOR 120; GLYCOPROTEIN P 15095; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LINOLENIC ACID; LYMPHOCYTE ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIPID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; HOMA INDEX; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; MACROPHAGE FUNCTION; MACROPHAGE INFILTRATION; MACROPHAGE POLARIZATION; MALE; MARKER GENE; MASS FRAGMENTOGRAPHY; MEDICAL PARAMETERS; METABOLIC DISORDER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHOSPHOLIPID BLOOD LEVEL; PROTEIN INDUCTION; THERAPY EFFECT; TREATMENT DURATION; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; MACROPHAGE; METABOLISM; ORGAN SIZE; PATHOLOGY; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADIPOSITY; ALPHA-LINOLENIC ACID; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; DIET, HIGH-FAT; FASTING; FATTY ACIDS, OMEGA-6; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MACROPHAGES; MALE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PHOSPHOLIPIDS; TREATMENT OUTCOME;

EID: 84899634514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103378     Document Type: Erratum

References (30)

1. Lawrence VJ, Kopelman PG (2004) Medical consequences of obesity. Clin Dermatol 22: 296-302.
2. Enos RT, Davis JM, Velazquez KT, McClellan JL, Day SD, et al. (2013) Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters. J Lipid Res 54: 152-163.
3. Simopoulos AP (2011) Importance of the omega-6/omega-3 balance in health and disease: evolutionary aspects of diet. World Rev Nutr Diet 102: 10-21.
4. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C (2011) Health implications of high dietary omega-6 polyunsaturated Fatty acids. J Nutr Metab 2012: 539426.
5. Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233: 674-688.
6. Simopoulos AP (1999) Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 60: 421-429.
7. Eaton SB, Eaton SB, 3rd, Sinclair AJ, Cordain L, Mann NJ (1998) Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. World Rev Nutr Diet 83: 12-23.
8. Crawford MA (1968) Fatty-acid ratios in free-living and domestic animals. Possible implications for atheroma. Lancet 1: 1329-1333.
9. Cordain L, Watkins BA, Mann NJ (2001) Fatty acid composition and energy density of foods available to African hominids. Evolutionary implications for human brain development. World Rev Nutr Diet 90: 144-161.
10. Grotto D, Zied E (2010) The Standard American Diet and its relationship to the health status of Americans. Nutr Clin Pract 25: 603-612.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
12. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
13. Saunders RD, Horrocks LA (1984) Simultaneous extraction and preparation for high-performance liquid chromatography of prostaglandins and phospholipids. Anal Biochem 143: 71-75.
14. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, et al. (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49: 2109-2119.
15. Madsen L, Kristiansen K (2012) Of mice and men: Factors abrogating the antiobesity effect of omega-3 fatty acids. Adipocyte 1: 173-176.
16. Kim W, McMurray DN, Chapkin RS (2010) n-3 polyunsaturated fatty acids- physiological relevance of dose. Prostaglandins Leukot Essent Fatty Acids 82: 155-158.
17. Ganesan B, Brothersen C, McMahon DJ (2013) Fortification of foods with omega-3 polyunsaturated Fatty acids. Crit Rev Food Sci Nutr 54: 98-114.
18. Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83: 1467S-1476S.
19. Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68: 280-289.
20. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulinsensitizing effects. Cell 142: 687-698.
21. Leyton J, Drury PJ, Crawford MA (1987) Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat. Br J Nutr 57: 383-393.
22. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
23. Chatterjee P, Seal S, Mukherjee S, Kundu R, Ray S, et al. (2013) Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages. J Biol Chem 288: 28324-28330.
24. Nara N, Nakayama Y, Okamoto S, Tamura H, Kiyono M, et al. (2007) Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesityinduced insulin resistance. J Biol Chem 282: 30794-30803.
25. Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, et al. (2001) Monocyte selectivity and tissue localization suggests a role for breast and kidneyexpressed chemokine (BRAK) in macrophage development. J Exp Med 194: 855-861.
26. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM (2011) Fats, inflammation and insulin resistance: insights to the role of macrophage and Tcell accumulation in adipose tissue. Proc Nutr Soc 70: 408-417.
27. Gotoh C, Hong YH, Iga T, Hishikawa D, Suzuki Y, et al. (2007) The regulation of adipogenesis through GPR120. Biochem Biophys Res Commun 354: 591-597.
28. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483: 350-354.
29. Talukdar S, Olefsky JM, Osborn O (2011) Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci 32: 543-550.
30. Stark AH, Crawford MA, Reifen R (2008) Update on alpha-linolenic acid. Nutr Rev 66: 326-332.